The higher expression of VDAC, high mitochondria mass, and sensitivity to MOMP can also facilitate the therapeutic effect of cisplatin in HNSCC as cisplatin preferentially binds mitochondrial DNA and VDAC in the mitochondrial membrane42. The gene discussed is VDAC1; the disease is head and neck squamous cell carcinoma.